The ACD is excited to announce the launch of our CCDS Research & Education Grants funding program. We are anticipating awarding grants on an ongoing basis. Look for updates soon. Please direct questions to [email protected].
Gene Therapy Advancement Award
The ACD is proud to support gene therapy research and as part of our Gene Therapy Consortium, we’ve created the Gene Therapy Advancement (GTA) Award. Each grant will be up to a limit of $10,000 and is proposed to be used towards capacity building, resource/tool creation, or fulfillment of experiment. To apply for the GTA award, each researcher can submit a short proposal where the goals of the proposal and impact of the results will be outlined. Each proposal will be evaluated by the ACD board consisting of patient advocates and scientific researchers.
The Q1 GTA awards are now open and ACD is accepting applications for funding. We encourage researchers to apply for these awards. To learn more, including how to apply for these awards, please visit this page.
Each grant will be up to a limit of $10,000 and can be used towards capacity building, resource/tool creation, or fulfillment of experiment.
Dates of application:
Q1 2021- March 1st- April 15th
To apply for a GTA grant, please provide the following:
- 1-page proposal — Please include the following: Goal, Funds requested, Impact for CCDS community (i.e. shared resources or publication)
- CV/Biosketch of Applicant
ACD Fellowships: Request for Applications
The Association for Creatine Deficiencies (ACD) is pleased to announce a call for fellowship applications. Each fellowship award carries a letter of recognition and funding of $30,000 per year for up to two years. Preference will be given to applicants who are early in their careers (graduate students, postdocs/research associates). All topics will be considered but preference will be given to proposals that facilitate progress to the clinic e.g. method/assay development for biomarkers, model/reagent development, drug screening, etc.
To apply for an ACD fellowship, please provide the following:
- Proposal with specific aims, methods and impact statement (no more than 5 pages)
- Letter of support
Dates of application:
August 1st, 2020 – November 1st, 2020
Each proposal will be evaluated by the ACD board consisting of patient advocates and scientific researchers. A decision will be conveyed by December 2020 with funding to commence by January 31st, 2021.
As part of this opportunity, ACD fellows will be introduced and requested to present their work at a special session in the 2021 Annual CCDS Symposium. To be eligible for Year 2 of funding, the ACD fellow will be expected to present progress made over the Year 1 and project plans for Year 2 of funding.
For more information, please contact [email protected]